Step 1: Understanding the Concept:
Recombinant protein subunit vaccines express only immunoprotective surface envelope proteins, eliminating live pathogen reversion and reactogenicity risks.
Step 2: Detailed Explanation:
Recombinant Hepatitis B Subunit Vaccine:
- The recombinant vaccine consists solely of the non-infectious Hepatitis B Surface Antigen (HBsAg) cloned and expressed as virus-like particles (VLPs) in baker's yeast (Saccharomyces cerevisiae) or CHO cells.
- Because the vaccine contains only the purified protective surface subunit antigen and completely lacks viral DNA, core antigens, or intact replication-competent virus, it induces robust neutralizing anti-HBs antibodies while eliminating live virus transmission risks and minimizing adverse hypersensitivity/toxic side effects.
Step 3: Final Answer:
Hence, its success is because Sub unit vaccine made only with the essential antigens ensures adverse reaction chances are minimized, matching option (A).